Trial Profile
Intracoronary stenting and angiographic results: Test efficacy of 3 limus-eluting stents (ISAR-TEST 4): Prospective, randomized trial of 3-limus agent-eluting stents with different polymer coatings.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2022
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Everolimus
- Indications Acute coronary syndromes; Coronary artery disease; Coronary artery restenosis; Myocardial infarction; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms ISAR-TEST-4
- 01 Jul 2022 Results (n=4953) of a post-hoc analysis assessing target and non-target vessel related events at 10 years from two clinical studies: NCT00598676 and NCT00598533 published in the Clinical Research in Cardiology
- 07 Dec 2015 Pooled analysis results of propensity-matched analysis from DESSOLVE I, DESSOLVE II and ISAR-TEST-4 study published in the American Journal of Cardiology.
- 19 May 2015 Retrospective patient level propensity-matched analysis, comparing data from the DESSOLVE I and DESSOLVE II compared to ISAR-TEST-4 study, presented at the official congress of European Association of Percutaneous Cardiovascular Interventions, as reported by Micell Technologies media release.